Evidence map›Paper›PMID 38312504›Full record

ArticleDevice2024

Biorobotic hybrid heart as a benchtop cardiac mitral valve simulator.

Clara Park, Manisha Singh, Mossab Y Saeed, Christopher T Nguyen, Ellen T Roche

Open access · hybridAbstract read
In one paragraph

Article in Device, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. A Soft Robotic Model for Simulating Heart Valve Disease and Cardiac Interventions.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Soft robotic devices for cardiovascular medicine.Nature reviews. Cardiology · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Refillable silicone pump with precise switching for timed therapeutic delivery.Frontiers in bioengineering and biotechnology · 2025
    Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Clara ParkInstitute for Medical Engineering and Science, Massachusetts Institute of Technology; Cambridge, MA, USA 02139.
Manisha SinghInstitute for Medical Engineering and Science, Massachusetts Institute of Technology; Cambridge, MA, USA 02139.
Mossab Y SaeedDepartment of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA 02115.
Christopher T NguyenCardiovascular Research Center, Massachusetts General Hospital; Charlestown, MA, USA 02114.
Ellen T RocheInstitute for Medical Engineering and Science, Massachusetts Institute of Technology; Cambridge, MA, USA 02139.
Massachusetts Institute of Technology · USBoston Children's Hospital · USCleveland Clinic · US

Funding

Mechanical Augmentation of the Diaphragm for End-Stage Respiratory FailureR21EB028414 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ROCHE, ELLEN T. · 2020 to 2020
$603k
Modulation of pressure overload in chronic animal and in vitro models to elucidate associated effects on hemodynamics and left ventricular plasticityR56HL166813 · NHLBI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ROCHE, ELLEN T. · 2023 to 2023
$362k
NHLBI NIH HHS R56 HL166813NIBIB NIH HHS R21 EB028414
6 · The paper itself

Abstract

In this work, we developed a high-fidelity beating heart simulator that provides accurate mitral valve pathophysiology. The benchtop platform is based on a biorobotic hybrid heart that combines preserved intracardiac tissue with soft robotic cardiac muscle providing dynamic left ventricular motion and precise anatomical features designed for testing intracardiac devices, particularly for mitral valve repair. The heart model is integrated into a mock circulatory loop, and the active myocardium drives fluid circulation producing physiological hemodynamics without an external pulsatile pump. Using biomimetic soft robotic technology, the heart can replicate both ventricular and septal wall motion, as well as intraventricular pressure-volume relationships. This enables the system to recreate the natural motion and function of the mitral valve, which allows us to demonstrate various surgical and interventional techniques. The biorobotic cardiovascular simulator allows for real-time hemodynamic data collection, direct visualization of the intracardiac procedure, and compatibility with clinical imaging modalities.

Identifiers

PMID38312504
PMCPMC10836162
OpenAlexW4390694380

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.